Our technology is based upon patented hydrogels, comprising
97.5% water and 2.5% cross-linked polyacrylamide.
Once injected, the homogenous, biocompatible, viscoelastic hydrogel maintains its volume by continually
exchanging water with the surrounding host tissues. They are permeable to salts and organic molecules, allowing cells to
integrate through the gel after injection.